161 research outputs found
The macrophage C-type lectin receptor CLEC5A (MDL-1) expression is associated with early plaque progression and promotes macrophage survival
CLEC5A Regulates Japanese Encephalitis Virus-Induced Neuroinflammation and Lethality
CLEC5A/MDL-1, a member of the myeloid C-type lectin family expressed on macrophages and neutrophils, is critical for dengue virus (DV)-induced hemorrhagic fever and shock syndrome in Stat1−/− mice and ConA-treated wild type mice. However, whether CLEC5A is involved in the pathogenesis of viral encephalitis has not yet been investigated. To investigate the role of CLEC5A to regulate JEV-induced neuroinflammation, antagonistic anti-CLEC5A mAb and CLEC5A-deficient mice were generated. We find that Japanese encephalitis virus (JEV) directly interacts with CLEC5A and induces DAP12 phosphorylation in macrophages. In addition, JEV activates macrophages to secrete proinflammatory cytokines and chemokines, which are dramatically reduced in JEV-infected Clec5a−/− macrophages. Although blockade of CLEC5A cannot inhibit JEV infection of neurons and astrocytes, anti-CLEC5A mAb inhibits JEV-induced proinflammatory cytokine release from microglia and prevents bystander damage to neuronal cells. Moreover, JEV causes blood-brain barrier (BBB) disintegrity and lethality in STAT1-deficient (Stat1−/−) mice, whereas peripheral administration of anti-CLEC5A mAb reduces infiltration of virus-harboring leukocytes into the central nervous system (CNS), restores BBB integrity, attenuates neuroinflammation, and protects mice from JEV-induced lethality. Moreover, all surviving mice develop protective humoral and cellular immunity against JEV infection. These observations demonstrate the critical role of CLEC5A in the pathogenesis of Japanese encephalitis, and identify CLEC5A as a target for the development of new treatments to reduce virus-induced brain damage
Dual roles for regulatory T cell depletion and co-stimulatory signaling in agonistic GITR targeting for tumor immunotherapy
Differential activity of IL-12 and IL-23 in mucosal and systemic innate immune pathology
Figure S3 from GITR Agonism Enhances Cellular Metabolism to Support CD8<sup>+</sup> T-cell Proliferation and Effector Cytokine Production in a Mouse Tumor Model
PhosFlow and Ki67 data</p
Figure S2 from GITR Agonism Enhances Cellular Metabolism to Support CD8<sup>+</sup> T-cell Proliferation and Effector Cytokine Production in a Mouse Tumor Model
MEK/PI3K Data</p
Figure S1 from GITR Agonism Enhances Cellular Metabolism to Support CD8<sup>+</sup> T-cell Proliferation and Effector Cytokine Production in a Mouse Tumor Model
Metabolic Inhibitors</p
Supplementary Figure Legends from GITR Agonism Enhances Cellular Metabolism to Support CD8<sup>+</sup> T-cell Proliferation and Effector Cytokine Production in a Mouse Tumor Model
Legends for the 3 Supplementary Figure Legends</p
- …
